22 May Synthetic Human Angiotensin II for the Treatment of Vasodilatory Shock
Posted at 19:46h
in Author Interviews, Blood Pressure - Hypertension, Cleveland Clinic, Critical Care - Intensive Care - ICUs, Infections, NEJM
MedicalResearch.com Interview with:
[caption id="attachment_34772" align="alignleft" width="159"]
Dr. Khanna[/caption]
Ashish Khanna, MD, FCCP
Assistant Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine
Staff Intensivist
Center for Critical Care and Department of Outcomes Research
Cleveland Clinic, Cleveland
MedicalResearch.com: How did you become interested in this topic?
Response: Anesthesia forms the basis of my training but I also completed a fellowship in critical care and, at the present time, I do more work in critical care than anesthesia. About 75% of my time is spent in the Cleveland Clinic critical care units, including the Medical and surgical ICUs (Intensive Care Units).























